Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 131 to 140

STOCRIN (efavirenz) 200 mg tablet bulk Japan (export only) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
STOCRIN (efavirenz) 600 mg tablet bulk Japan (export only) Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
MODURETIC TABLET 5 mg/50 mg Spanish blister export only Cancelled under s30(1)(c) of the Act

5 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PROQUAD FROZEN measles, mumps, rubella, varicella live virus vaccine injection vial Cancelled under s30(1)(c) of the Act

2 June 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
XELEVIA sitagliptin (as phosphate monohydrate) 100 mg tablet blister pack Cancelled under s30(1)(c )

17 February 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
XELEVIA sitagliptin (as phosphate monohydrate) 50 mg tablet blister pack Cancelled under s30(1)(c )

17 February 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
XELEVIA sitagliptin (as phosphate monohydrate) 25 mg tablet blister pack Cancelled under s30(1)(c )

17 February 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
EULEXIN flutamide 250mg tablet blister pack Cancelled under s30(1)(c )

10 February 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
FUGEREL flutamide 250mg tablet blister pack Cancelled under s30(1)(c )

10 February 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
NOROXIN norfloxacin 400mg tablet blister pack Cancelled under s30(1)(c )

29 October 2014

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Current page 14
Page 15
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.